Journal of Clinical Endocrinology & Metabolism, Vol 53, 174-178, Copyright © 1981 by Endocrine Society

ARTICLES

Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus

RG Lahita, HL Bradlow, HG Kunkel and J Fishman

Systemic lupus erythematosus (SLE) is one of many chronic diseases with a predilection for the human female. The reasons for the high female to male (9:1) incidence remain unknown. The total extent of hydroxylation estradiol at either C-16 to more estrogenic metabolites or at C-2 to the catechol estrogens was determined by a radiometric method in the human. Comparing 23 SLE patients to 44 normal controls, an increase in the extent of hydroxylation toward the 16 alpha-metabolites was found in SLE (SLE 15.2 +/- 4.3%, range 8.8-30%; normal 9.1 +/- 2.3%, range 5.3-14.4%; P less than 0.001). Increased 16 alpha-hydroxylation was found in both males (SLE 13.2 +/- 3.0%, normal 8.3 +/- 2.1%) and females (SLE 15.7 +/- 5%, normal 9.9 +/- 2.2%) with disease when compared to normal subjects. In addition, studies of several other chronic diseases by the same method did not indicate a similar alteration in 16 hydroxylation. No change in hydroxylation at C-2 was found in male patients, but a decrease was found in female patients. These data suggest that increased hydroxylation of estradiol at C-16 occurs in SLE. The 16 alpha-metabolites have been shown to be potent estrogens, and these data might give some insight into the pathogenesis of the disease.

This article has been cited by other articles:

				R. H. Straub The Complex Role of Estrogens in Inflammation Endocr. Rev., August 1, 2007; 28(5): 521 - 574. [Abstract] [Full Text] [PDF]

				X Li, V Rider, B F Kimler, and N I Abdou Estrogen does not regulate CD154 mRNA stability in systemic lupus erythematosus T cells Lupus, December 1, 2006; 15(12): 852 - 857. [Abstract] [PDF]

				M J Eikelenboom, J Killestein, B M. Uitdehaag, and C H Polman Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis Multiple Sclerosis, October 1, 2005; 11(5): 520 - 523. [Abstract] [PDF]

				E. Peeva, J. Venkatesh, and B. Diamond Tamoxifen Blocks Estrogen-Induced B Cell Maturation but Not Survival J. Immunol., August 1, 2005; 175(3): 1415 - 1423. [Abstract] [Full Text] [PDF]

				P H Schur and M Liang Henry Kunkel Festschrift Lupus, March 1, 2003; 12(3): 153 - 156. [Abstract] [PDF]

				S M Fu, J D Castillo, U S Deshmukh, J E Lewis, S T Waters, and F Gaskin Autoantibodies and glomerulonephritis in systemic lupus erythematosus Lupus, March 1, 2003; 12(3): 175 - 180. [Abstract] [PDF]

				M Petri Diet and systemic lupus erythematosus: from mouse and monkey to woman? Lupus, November 1, 2001; 10(11): 775 - 777. [PDF]

				T E McAlindon, J Gulin, T Chen, T Klug, R Lahita, and M Nuite Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity Lupus, November 1, 2001; 10(11): 779 - 783. [PDF]

				C C Mok and C S Lau Profile of sex hormones in male patients with systemic lupus erythematosus Lupus, May 1, 2000; 9(4): 252 - 257. [Abstract] [PDF]

				S. MANZI, M. C. M WASKO, and S. MANZI Inflammation-mediated rheumatic diseases and atherosclerosis Ann Rheum Dis, May 1, 2000; 59(5): 321 - 325. [Full Text]

				S. Kortunay, A. Bozkurt, L. Bathum, N. E Basci, M. Çalgüneri, and K. Brøsen CYP2C19 genotype does not represent a genetic predisposition in idiopathic systemic lupus erythematosus Ann Rheum Dis, March 1, 1999; 58(3): 182 - 185. [Abstract] [Full Text]

				M. CUTOLO, A. SULLI, B. VILLAGGIO, B. SERIOLO, and S. ACCARDO Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus Ann Rheum Dis, October 1, 1998; 57(10): 573 - 577. [Full Text]

				K B Elbourne, D Keisler, and R W McMurray Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus Lupus, July 1, 1998; 7(6): 420 - 427. [Abstract] [PDF]

				M. CUTOLO Do sex hormones modulate the synovial macrophages in rheumatoid arthritis? Ann Rheum Dis, May 1, 1997; 56(5): 281 - 283. [Full Text]

				H. McGrath JR Prospects for UV-Al therapy as a treatment modality in cutaneous and systemic LE Lupus, January 1, 1997; 6(2): 209 - 217. [PDF]

				R. Suenaga, K. Mitamura, M. Evans, and N. Abdou Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus Lupus, June 1, 1996; 5(3): 227 - 231. [Abstract] [PDF]

				R.G. Lahita Sex Steroids and SLE: Metabolism of Androgens to Estrogens Lupus, May 1, 1992; 1(3): 125 - 127. [PDF]